Mon panier

SARS-CoV-2 (WT) Inhibitor Screening Kit (Spike RBD)

Avis des utilisateurs
Numéro de produit/spécification
Prix
Qté
EP-107-96tests
$715.00
ETA of in-stock products:2 business days
Total des articles Montant du produit$ 0

Détails du produit

  • Materials Provided

    ID
    Components
    Size
    EP107-C01
    Pre-coated Human ACE2 Microplate
    1 plate
    EP107-C02
    SARS-CoV-2 Inhibitor
    10 μg
    EP107-C03
    HRP-SARS-CoV-2 Spike RBD(WT)
    15 μg
    EP107-C04
    10xWashing Buffer
    50 mL
    EP107-C05
    Dilution Buffer
    50 mL
    EP107-C06
    Substrate Solution
    12 mL
    EP107-C07
    Stop Solution
    7 mL

  • Product Overview

    The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) poses continual threat to human health due to rapid transmission worldwide. The deleloped of effcient treatment agaginst SARS-CoV-2 is an emergent need for global pubic heath,and it is necessary to develop SARS-CoV-2 inhibitors, such as vaccines, therapeutic antibodies and small molecule compounds against SARS-CoV-2.

    Therefore, it is helpful to develop the SARS-CoV-2 (WT) Inhibitor Screening Kit (Spike RBD) to test SARS-CoV-2 inhibitors.

  • Application

    This kit is developed for screening inhibitors of SARS-CoV-2 (WT).

    It is for research use only.

  • Reconstitution

    Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.

  • Storage

    1. Unopened kit should be stored at 2℃-8℃ upon receiving.

    2. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

    3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Les clients ont également consulté

Affichage des données

  • Typical Data 

    Please refer to DS document for the assay protocol.

     Spike RBD TYPICAL DATA

    Incubation of SARS-CoV-2 inhibitor:Blocking the binding of HRP-SARS-CoV-2 Spike RBD(WT) to Human ACE2.
    Serial dilutions of SARS-CoV-2 inhibitor (Catalog # EP107-C02) (1:1 serial dilutions, from 5.0ug/mL to 0.0098ug/mL(34.4nM to 0.07nM)) and loaded onto the plate coated by human ACE2 in the presence of HRP-SARS-CoV-2 Spike RBD(WT).Background was subtracted from data points prior to log transformation and curve fitting (QC tested).

Avis des utilisateurs
Publier un commentaire

Progrès de frontière

 
Drug Candidate Licensing
More
  • Informations de base sur le produit
  • Détails du produit
  • Les clients ont également consulté
  • Affichage des données
  • Avis des utilisateurs